Table 2

Number of cases and crude incidence rates (IR) per 100 000 for lymphoid malignancies by sex and morphologic type diagnosed in 2000-2002 and archived in 44 European CRs

HAEMACARE groupingsICD-O-3 codeICD-O-3 descriptionNo. of casesAllMalesFemales
IR95% CIIR95% CIIR95% CI
HL55712.49(2.42-2.55)2.81(2.71-2.91)2.18(2.09-2.26)
    HL, nodular lymphocyte predominance9659HL, nodular lymphocyte predominance1950.09(0.08-0.10)0.12(0.10-0.15)0.05(0.04-0.07)
    Classic HL53762.40(2.34-2.47)2.69(2.59-2.79)2.12(2.04-2.21)
9650HL, NOS9960.44(0.42-0.47)0.52(0.48-0.57)0.37(0.34-0.41)
9661Hodgkin granuloma (obsolete)
9662Hodgkin sarcoma (obsolete)
9651HL, lymphocyte rich2170.10(0.08-0.11)0.13(0.11-0.15)0.07(0.05-0.08)
9663HL, nodular sclerosis, NOS31651.41(1.36-1.46)1.45(1.38-1.53)1.37(1.31-1.44)
9664HL, nodular sclerosis cellular phase
9665HL, nodular sclerosis grade 1
9667HL, nodular sclerosis grade 2
9652HL, mixed cellularity, NOS9090.41(0.38-0.43)0.53(0.49-0.58)0.28(0.25-0.32)
9653HL, lymphocyte depletion, NOS890.04(0.03-0.05)0.05(0.04-0.07)0.03(0.02-0.04)
9654HL, lymphocyte depletion, diffuse fibrosis
9655HL, lymphocyte depletion, reticular
Mature B-cell neoplasms42 85519.14(18.96-19.32)21.30(21.03-21.57)17.07(16.83-17.31)
    SBLL/CLL9670Malignant lymphoma, small B-cell lymphocytic, NOS11 0194.92(4.83-5.01)5.87(5.73-6.02)4.01(3.90-4.13)
9823B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
    Immunoproliferative diseases9671Malignant lymphoma, lymphoplasmacytic18590.83(0.79-0.87)1.00(0.94-1.06)0.67(0.63-0.72)
9760Immunoproliferative disease, NOS
9761Waldenström macroglobulinemia
9762Heavy chain disease, NOS
    Mantle cell/centrocytic lymphoma9673Mantle cell lymphoma10120.45(0.42-0.48)0.64(0.60-0.69)0.27(0.24-0.30)
    Follicular B-cell lymphoma9690Follicular lymphoma, NOS48812.18(2.12-2.24)2.10(2.01-2.19)2.26(2.17-2.35)
9691Follicular lymphoma, grade 2
9695Follicular lymphoma, grade 1
9698Follicular lymphoma, grade 3
    Diffuse B-cell lymphoma9675Malignant lymphoma, mixed small and large cell, diffuse (obsolete)85383.81(3.73-3.89)4.06(3.95-4.19)3.57(3.46-3.68)
9678Primary effusion lymphoma
9679Mediastinal large B-cell lymphoma
9680Malignant lymphoma, large B-cell, diffuse, NOS
9684Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS
    Burkitt lymphoma/leukemia9687Burkitt lymphoma, NOS4880.22(0.20-0.24)0.31(0.27-0.34)0.13(0.11-0.16)
9826Burkitt cell leukemia
    Marginal zone lymphoma9689Splenic marginal zone B-cell lymphoma9500.42(0.40-0.45)0.40(0.36-0.44)0.45(0.41-0.49)
9699Marginal zone B-cell lymphoma, NOS/mucosa-associated lymphoid tissue lymphoma
9764Immunoproliferative small intestinal disease (Mediterranean lymphoma)
    Mature B-cell leukemia9833Prolymphocytic leukemia, B-cell type6520.29(0.27-0.31)0.46(0.42-0.50)0.13(0.11-0.15)
9940Hairy cell leukemia
    Plasma cell neoplasms13 4566.01(5.91-6.11)6.46(6.31-6.61)5.58(5.44-5.72)
9732Multiple myeloma12 1925.44(5.35-5.54)5.85(5.70-5.99)5.06(4.93-5.19)
9733Plasma cell leukemia920.04(0.03-0.05)0.04(0.03-0.05)0.05(0.03-0.06)
9731Plasmacytoma, NOS11720.52(0.49-0.55)0.58(0.53-0.62)0.47(0.43-0.51)
9734Plasmacytoma, extramedullary
Mature T-cell and NK-cell neoplasms25271.13(1.08-1.17)1.41(1.34-1.48)0.86(0.81-0.92)
    Cutaneous T-cell lymphoma9700Mycosis fungoides12080.54(0.51-0.57)0.68(0.64-0.73)0.40(0.37-0.44)
9701Sézary syndrome
9708Subcutaneous T panniculitis-like T-cell lymphoma
9709Cutaneous T-cell lymphoma, NOS
9718Primary cutaneous CD30+ T-cell lymphoproliferative disorder
    Other T-cell lymphomas9702Mature T-cell lymphoma, NOS13190.59(0.56-0.62)0.72(0.67-0.78)0.46(0.42-0.50)
9705Angioimmunoblastic T-cell lymphoma
9714Anaplastic large cell lymphoma, T-cell and null cell type
9716Hepatosplenic γδ cell lymphoma
9717Intestinal T-cell lymphoma
9948Aggressive NK-cell leukemia
9719NK/T-cell lymphoma, nasal and nasal-type
9827Adult T-cell leukemia/lymphoma (HTLV-1 positive)
9831T-cell large granular lymphocytic leukemia
9834Prolymphocytic leukemia, T-cell type
Lymphoblastic lymphoma/acute (precursor cell) lymphatic leukemia28631.28(1.23-1.33)1.44(1.37-1.51)1.12(1.06-1.19)
    B-cell9728Precursor B-cell lymphoblastic lymphoma1900.08(0.07-0.10)0.09(0.07-0.11)0.08(0.06-0.10)
9836Precursor B-cell lymphoblastic leukemia
    T-cell9729Precursor T-cell lymphoblastic lymphoma640.03(0.02-0.04)0.04(0.03-0.06)0.01(0.01-0.02)
9837Precursor T-cell lymphoblastic leukemia
    NOS9727Precursor cell lymphoblastic lymphoma, NOS26091.17(1.12-1.21)1.31(1.24-1.38)1.03(0.97-1.09)
9835Precursor cell lymphoblastic leukemia, NOS
Unknown lymphoid neoplasms12 5475.60(5.51-5.70)5.87(5.72-6.01)5.35(5.22-5.49)
    Lymphoma, NOS9590Malignant lymphoma, NOS48032.14(2.08-2.21)2.21(2.12-2.30)2.09(2.00-2.17)
    NHL, NOS9591Malignant lymphoma, NHL, NOS74503.33(3.25-3.40)3.51(3.40-3.62)3.15(3.05-3.25)
    Lymphatic leukemia, NOS9820Lymphoid leukemia, NOS2940.13(0.12-0.15)0.15(0.13-0.17)0.12(0.10-0.14)
9832Prolymphocytic leukemia, NOS
All lymphoid malignancies*66 37129.64(29.41-29.86)32.83(32.49-33.17)26.59(26.29-26.89)
  • * Eight cases of composite HL and NHL (ICD-O-3 code 9596) not shown in Table 2 have been included in the totals.